Cargando…
Targeting pathogenic macrophages by the application of SHP-1 agonists reduces inflammation and alleviates pulmonary fibrosis
Idiopathic pulmonary fibrosis is a progressive fibrotic disorder with no cure that is characterized by deterioration of lung function. Current FDA-approved drugs for IPF delay the decline in lung function, but neither reverse fibrosis nor significantly improve overall survival. SHP-1 deficiency resu...
Autores principales: | Hong, Shiao-Ya, Lu, Ya-Ting, Chen, Shih-Yu, Hsu, Chiung-Fang, Lu, Yi-Chun, Wang, Cheng-Yi, Huang, Kun-Lun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249559/ https://www.ncbi.nlm.nih.gov/pubmed/37291088 http://dx.doi.org/10.1038/s41419-023-05876-z |
Ejemplares similares
-
Dioscin Alleviates Crystalline Silica-Induced Pulmonary Inflammation and Fibrosis through Promoting Alveolar Macrophage Autophagy
por: Du, Sitong, et al.
Publicado: (2019) -
Phosphatase Shp2 exacerbates intestinal inflammation by disrupting macrophage responsiveness to interleukin-10
por: Xiao, Peng, et al.
Publicado: (2019) -
Antiliver Fibrosis Formula of Fuzheng Huayu Alleviates Inflammatory Response
por: Chang, Qing-Qi, et al.
Publicado: (2022) -
Nobiletin Alleviates Ferroptosis-Associated Renal Injury, Inflammation, and Fibrosis in a Unilateral Ureteral Obstruction Mouse Model
por: Lo, Yi-Hsin, et al.
Publicado: (2022) -
Quercetin Alleviates Pulmonary Fibrosis in Mice Exposed to Silica by Inhibiting Macrophage Senescence
por: Geng, Fei, et al.
Publicado: (2022)